Abstract
Hilar cholangiocarcinoma has a poor prognosis and surgery remains the only curative option. However, few patients are diagnosed at a curable stage and palliative therapies are, therefore, mandatory. Endoscopy could have a useful role in the work-up of patients with hilar cholangiocarcinoma who are unsuitable for surgery. Endoscopic retrograde cholangiopancreatography provides an opportunity to collect specimens for cytological or histological diagnosis, yet is often nondiagnostic. Other techniques, including fluorescence in situ hybridization, confocal laser endomicroscopy and endoscopic ultrasonography, are now improving the accuracy of tissue diagnosis. This Review presents an overview of the diagnostic and therapeutic role of endoscopic procedures in the management of hilar cholangiocarcinoma. The use of such procedures in guiding the therapeutic management of patients with hilar cholangiocarcinoma is discussed, and the relative success of endoscopic stenting as the main palliative therapy for obstructive jaundice (a common complication of hilar cholangiocarcinoma) is described. The potential role of photodynamic therapy as a palliative treatment for patients with hilar cholangiocarcinoma is also outlined.
Key Points
-
Endoscopic retrograde cholangiopancreatography (ERCP) enables the collection of tissue specimens from patients with hilar cholangiocarcinoma who are unsuitable for surgery
-
Fluorescence in situ hybridization and confocal laser endomicroscopy could improve the accuracy of diagnosis of malignancy in patients with hilar strictures
-
The choice between percutaneous and endoscopic biliary drainage should be based on the local availability of relevant expertise
-
ERCP should not to be performed in patients with hilar strictures who can be referred for surgery
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Khan, S. A. et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 37, 806–813 (2002).
Shaib, Y. & El-Serag, H. B. The epidemiology of cholangiocarcinoma. Semin. Liver Dis. 24, 115–125 (2004).
Khan, S. A., Thomas, H. C., Davidson, B. R. & Taylor-Robinson, S. D. Cholangiocarcinoma. Lancet 366, 1303–1314 (2005).
Watanapa, P. & Watanapa, W. B. Liver fluke-associated cholangiocarcinoma. Br. J. Surg. 89, 962–970 (2002).
Shaib, Y. H. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case–control study. Am. J. Gastroenterol. 102, 1016–1021 (2007).
Walker, N. J. et al. Dose-additive carcinogenicity of a defined mixture of “dioxin-like compounds”. Environ. Health Perspect. 113, 43–48 (2005).
Welzel, T. M., McGlynn K. A., Hsing, A. W., O'Brien, T. R. & Pfeiffer, R. M. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J. Natl Cancer Inst. 21, 873–875 (2006).
Nimura, Y., Hayakawa, N., Kamiya, J., Kondo, S. & Shionoya, S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J. Surg. 14, 535–543 (1990).
Wetter, L. A., Ring, E. J., Pellegrini, C. A. & Way, L. W. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am. J. Surg. 161, 57–62 (1991).
Jarnagin, W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 234, 507–517 (2001).
Sobin, L. H., Gospodarowicz, M. K. & Wittekind, C. in TNM Classification of Malignant Tumours, 7th edn, 122–125 (Wiley-Blackwell, Oxford, 2009).
Bismuth, H. & Corlette, M. B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg. Gynecol. Obstet. 140, 170–178 (1975).
Lee, H. Y. et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239, 113–121 (2006).
Chen, H. W. et al. Preoperative evaluation of resectability of Klatskin tumor with 16-slice MDCT angiography and cholangiography. AJR Am. J. Roentgenol. 186, 1580–1586 (2006).
Park, H. S. et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am. J. Roentgenol. 190, 396–405 (2008).
Baron, T. H. et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest. Endosc. 58, 643–649 (2003).
de Bellis, M. et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest. Endosc. 58, 176–182 (2003).
Weber, A. et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J. Gastroenterol. 14, 1097–1101 (2008).
Bergquist, A., Tribukait, B., Glaumann, H. & Broome, U. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J. Hepatol. 33, 873–877 (2000).
Moreno Luna, L. E. et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131, 1064–1072 (2006).
Bangarulingam, S. Y. et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 51, 174–180 (2010).
Fritscher-Ravens, A. et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest. Endosc. 52, 534–540 (2000).
Rösch, T. et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest. Endosc. 60, 390–396 (2004).
Lee, J. H., Salem, R., Aslanian, H., Chacho, M. & Topazian, M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am. J. Gastroenterol. 99, 1069–1073 (2004).
Eloubeidi, M. A. et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 2, 209–213 (2004).
Fritscher-Ravens, A. et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 99, 45–51 (2004).
Byrne, M. F. et al. Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy 36, 715–719 (2004).
DeWitt, J., Misra, V. L., Leblanc, J. K., McHenry, L. & Sherman, S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest. Endosc. 64, 325–333 (2006).
Gleeson, F. C. et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest. Endosc. 67, 438–443 (2008).
Gores, G. J. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 6 (Suppl. 2), S30–S34 (2000).
Giovannini, M. et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a prospective multicenter study. World J. Gastroenterol. 7, 1587–1593 (2009).
Mentzel. J., Poremba, C., Dietl, K. H. & Domschke, W. Preoperative diagnosis of bile duct strictures—comparison of intraductal ultrasonography with conventional endosonography. Scand. J. Gastroenterol. 35, 77–82 (2000).
Stavaropoulos, S., Larghi, A., Verna, E., Battezzati, P. & Stevens, P. Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy 37, 715–721 (2005).
Domagk, D. et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am. J. Gastroenterol. 99, 1684–1689 (2004).
Kim, H. M. et al. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma. J. Gastroenterol. Hepatol. 25, 286–292 (2010).
Giovannini, M. et al. Results of a phase I–II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis. Surg. Endosc. 25, 2247–2253 (2011).
Sakamoto, E. et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann. Surg. 227, 405–411 (1998).
Itoi, T. et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest. Endosc. 66, 730–736 (2007).
Tischendorf, J. W. et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 38, 665–669 (2006).
Chen, Y. K. & Pleskow, D. K. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest. Endosc. 65, 832–841 (2007).
Smith, A. C., Dowsett, J. F., Russell, R. C., Hatfield, A. R. & Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 17, 1655–1660 (1994).
Pinol, V. et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225, 27–34 (2002).
Speer, A. G. et al. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 11, 57–62 (1987).
Paik, W. H. et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest. Endosc. 69, 55–62 (2009).
Giovannini, M. et al. Hepaticogastrostomy by echo-endoscopy as a palliative treatment in a patient with metastatic biliary obstruction. Endoscopy 35, 1076–1078 (2003).
Park, H. et al. EUS-guided hepaticogastrostomy with a fully covered metal stent as the biliary diversion technique for an occluded biliary metal stent after a failed ERCP (with videos). Gastrointest. Endosc. 71, 413–419 (2010).
De Palma, G. D., Galloro, G., Siciliano, S., Iovino, P. & Catanzano, C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest. Endosc. 53, 547–553 (2001).
Naitoh, I. et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J. Gastroenterol. Hepatol. 24, 552–557 (2009).
Vienne, A. et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest. Endosc. 72, 728–735 (2010).
Kennedy, T. J. et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11, 445–451 (2009).
Kaassis, M. et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest. Endosc. 57, 178–182 (2003).
Levy, M. J., Baron, T. H., Gostout, C. J., Petersen, B. T. & Farnell, M. B. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin. Gastroenterol. Hepatol. 2, 273–285 (2004).
Soderlund, C. & Linder, S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest. Endosc. 63, 986–995 (2006).
Wagner, H. J., Knyrim, K., Vakil, N. & Klose, K. J. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 25, 213–218 (1993).
Perdue, D. G. et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J. Clin. Gastroenterol. 42, 1040–1046 (2008).
De Palma, G. et al. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest. Endosc. 58, 50–53 (2003).
Singh, V., Singh, G., Verma, G. R., Singh, K. & Gulati, M. Contrast free unilateral endoscopic palliation in malignant hilar biliary obstruction: new method. J. Gastroenterol. Hepatol. 19, 589–592 (2004).
Dumas, R. et al. Endoscopic bilateral metal stent placement for malignant hilar stenoses: identification of optimal technique. Gastrointest. Endosc. 51, 334–338 (2000).
Shinchi, H., Takao, S., Nishida, H. & Aikou, T. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J. Surg. Oncol. 75, 89–94 (2000).
Cheng, J. L. et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest. Endosc. 56, 33–39 (2002).
Kawamoto, H. et al. Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures. Clin. Gastroenterol. Hepatol. 6, 401–408 (2008).
Chennat, J. & Waxman, I. Initial performance profile of a new 6F self-expanding metal stent for palliation of malignant hilar biliary obstruction. Gastrointest. Endosc. 72, 632–636 (2010).
Raju, R. P. et al. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig. Dis. Sci. 56, 1557–1564 (2011).
Peters, R. A., Williams, S. G. J., Lombard, M., Karani, J. & Westaby, D. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 28, 10–16 (1997).
Freeman M. L. & Overby, C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest. Endosc. 58, 41–49 (2003).
Hintze, R. E. et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest. Endosc. 53, 40–46 (2001).
Polydorou, A. A. et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32, 685–689 (1991).
Rerknimitr, R., Kladcharoen, N., Mahachai, V. & Kullavanijaya, P. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J. Clin. Gastroenterol. 38, 518–523 (2004).
Singh, V., Singh, G., Gupta, V., Gupta, R. & Kapoor, R. Contrast-free air cholangiography-assisted unilateral plastic stenting in malignant hilar biliary obstruction. Hepatobiliary Pancreat. Dis. Int. 9, 88–92 (2010).
Ortner, M. E. et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125, 1355–1363 (2003).
Zoepf, T., Jakobs, R., Arnold, J. C., Apel, D. & Riemann, J. F. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am. J. Gastroenterol. 100, 2426–2430 (2005).
Gerhardt, T. et al. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Z. Gastroenterol. 48, 28–32 (2010).
Witzigmann, H. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann. Surg. 244, 230–239 (2006).
Quyn, A. J., Ziyaie, D., Polignano, F. M. & Tait, I. S. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) 11, 570–577 (2009).
Fletcher, M. S., Brinkley, D., Dawson, J. L., Nunnerley, H. & Williams, R. Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire. Br. J. Surg. 70, 733–735 (1983).
Kuvshinoff, B. W. et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br. J. Surg. 82, 1522–1525 (1995).
Author information
Authors and Affiliations
Contributions
A. Parodi, D. Fisher and M. Conio wrote the manuscript. All authors contributed to researching the data for the article, discussions of the article content and review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Parodi, A., Fisher, D., Giovannini, M. et al. Endoscopic management of hilar cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 9, 105–112 (2012). https://doi.org/10.1038/nrgastro.2011.271
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2011.271
This article is cited by
-
TROP2 Correlates with Microvessel Density and Poor Prognosis in Hilar Cholangiocarcinoma
Journal of Gastrointestinal Surgery (2013)